Zacks Small Cap Research on MSN10h
RANI: Impressive Bioavailability for RT-116RANI READ THE FULL RANI RESEARCH REPORT On February 5th, Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) shared its preclinical readout from the RT-116 study demonstrating successful oral delivery of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback